Lucid Diagnostics Inc.

Lucid Diagnostics Inc.verified

LUCD

Price:

$0.774

Market Cap:

$45.93M

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.[Read more]

Industry

Medical - Devices

IPO Date

2021-10-14

Stock Exchange

NASDAQ

Ticker

LUCD

The PE Ratio as of December 2024 (TTM) for Lucid Diagnostics Inc. (LUCD) is -0.69

According to Lucid Diagnostics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.69. This represents a change of -31.41% compared to the average of -1.01 of the last 4 quarters.

Lucid Diagnostics Inc. (LUCD) Historical PE Ratio (quarterly & annually)

How has LUCD PE Ratio performed in the past?

The mean historical PE Ratio of Lucid Diagnostics Inc. over the last ten years is -90.97. The current -0.69 PE Ratio has changed -24.15% with respect to the historical average. Over the past ten years (40 quarters), LUCD's PE Ratio was at its highest in in the March 2023 quarter at -0.01. The PE Ratio was at its lowest in in the September 2020 quarter at -53.80.

Quarterly (TTM)
Annual

Average

-90.97

Median

-29.53

Minimum

-386.38

Maximum

-0.88

Lucid Diagnostics Inc. (LUCD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lucid Diagnostics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 27.65%

Maximum Annual PE Ratio = -0.88

Minimum Annual Increase = -87.58%

Minimum Annual PE Ratio = -386.38

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.1227.65%
2022-0.88-86.58%
2021-6.53-87.58%
2020-52.54-46.61%
2019-98.41-74.53%

Lucid Diagnostics Inc. (LUCD) Average PE Ratio

How has LUCD PE Ratio performed in the past?

The current PE Ratio of Lucid Diagnostics Inc. (LUCD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.84

5-year avg

-31.89

10-year avg

-90.97

Lucid Diagnostics Inc. (LUCD) PE Ratio vs. Peers

How is LUCD’s PE Ratio compared to its peers?

Lucid Diagnostics Inc.’s PE Ratio is greater than Inari Medical, Inc. (-41.85), less than Beyond Air, Inc. (-0.41), less than PAVmed Inc (0.32), greater than ClearPoint Neuro, Inc. (-24.94), less than ProSomnus, Inc. (-0.59), less than LivaNova PLC (119.60), less than Electromed, Inc. (37.86), greater than OrthoPediatrics Corp. (-17.86), greater than Surmodics, Inc. (-49.16), greater than NeuroPace, Inc. (-11.44), greater than Paragon 28, Inc. (-14.03), greater than CVRx, Inc. (-5.22), greater than Pulmonx Corporation (-4.16), less than IRadimed Corporation (37.02), greater than Orthofix Medical Inc. (-5.85), less than Integer Holdings Corporation (41.29),

Build a custom stock screener for Lucid Diagnostics Inc. (LUCD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lucid Diagnostics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lucid Diagnostics Inc. (LUCD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lucid Diagnostics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Lucid Diagnostics Inc.'s PE Ratio?

How is the PE Ratio calculated for Lucid Diagnostics Inc. (LUCD)?

What is the highest PE Ratio for Lucid Diagnostics Inc. (LUCD)?

What is the 3-year average PE Ratio for Lucid Diagnostics Inc. (LUCD)?

What is the 5-year average PE Ratio for Lucid Diagnostics Inc. (LUCD)?

How does the current PE Ratio for Lucid Diagnostics Inc. (LUCD) compare to its historical average?